Position in VCYT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$92,799,906
-$25,100,132 QoQ
Shares Held
2,881,090
+2.9% QoQ
Ownership
3.61%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 93%
Shared 4%
None 3%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $4,736,122,501 across 33 Diagnostics & Research names. VCYT ranks #13 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,689,790 | $830,582,476 | |
| 2 | DHR |
Danaher Corp /De/
|
2,645,911 | $501,664,724 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,949,535 | $382,069,866 | |
| 4 | LH |
Labcorp Holdings Inc.
|
1,332,775 | $355,597,695 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
573,332 | $322,149,515 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
1,652,484 | $285,053,489 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,657,696 | $282,703,474 | |
| 8 | RVTY |
Revvity, Inc.
|
2,917,953 | $255,641,860 |
All Filings in VCYT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,799,906 | 2,881,090 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $117,900,038 | 2,800,476 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $107,046,636 | 3,118,166 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $81,698,227 | 3,022,502 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $86,308,243 | 2,910,902 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $114,156,265 | 2,882,734 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $103,270,209 | 3,033,790 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $75,013,108 | 3,461,611 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $76,791,467 | 3,465,319 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $92,783,057 | 3,372,703 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $71,715,695 | 3,211,630 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $71,276,901 | 2,798,465 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $51,203,807 | 2,296,135 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,267,783 | 1,317,648 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $13,397,293 | 807,066 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $883,857 | 44,415 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $308,839 | 11,202 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $468,732 | 11,377 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,777,827 | 38,274 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,619,929 | 65,531 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $12,738,427 | 236,994 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,063,870 | 103,471 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $1,022,525 | 31,472 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||